Conduit Pharmaceuticals Stock Probability of Future Stock Price Finishing Under 0.00
| CDTTW Stock | 0.02 0.01 43.62% |
Conduit |
Conduit Pharmaceuticals Target Price Odds to finish below 0.00
The tendency of Conduit Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to drop to 0.00 or more in 90 days |
| 0.02 | 90 days | 0.00 | under 4 |
Based on a normal probability distribution, the odds of Conduit Pharmaceuticals to drop to 0.00 or more in 90 days from now is under 4 (This Conduit Pharmaceuticals probability density function shows the probability of Conduit Stock to fall within a particular range of prices over 90 days) . Probability of Conduit Pharmaceuticals price to stay between 0.00 and its current price of 0.0214 at the end of the 90-day period is about 50.98 .
Assuming the 90 days horizon Conduit Pharmaceuticals has a beta of 0.31 suggesting as returns on the market go up, Conduit Pharmaceuticals average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Conduit Pharmaceuticals will be expected to be much smaller as well. In addition to that Conduit Pharmaceuticals has an alpha of 4.1806, implying that it can generate a 4.18 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Conduit Pharmaceuticals Price Density |
| Price |
Predictive Modules for Conduit Pharmaceuticals
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Conduit Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Conduit Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Conduit Pharmaceuticals Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Conduit Pharmaceuticals is not an exception. The market had few large corrections towards the Conduit Pharmaceuticals' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Conduit Pharmaceuticals, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Conduit Pharmaceuticals within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 4.18 | |
β | Beta against Dow Jones | 0.31 | |
σ | Overall volatility | 0.01 | |
Ir | Information ratio | 0.12 |
Conduit Pharmaceuticals Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Conduit Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Conduit Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Conduit Pharmaceuticals is way too risky over 90 days horizon | |
| Conduit Pharmaceuticals has some characteristics of a very speculative penny stock | |
| Conduit Pharmaceuticals appears to be risky and price may revert if volatility continues | |
| Conduit Pharmaceuticals has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (535 K) with profit before overhead, payroll, taxes, and interest of 0. | |
| Conduit Pharmaceuticals generates negative cash flow from operations | |
| Conduit Pharmaceuticals has a frail financial position based on the latest SEC disclosures | |
| Latest headline from news.google.com: Whats Going On With Conduit Pharmaceuticals Shares Today - Benzinga |
Conduit Pharmaceuticals Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Conduit Stock often depends not only on the future outlook of the current and potential Conduit Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Conduit Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 67.9 M | |
| Cash And Short Term Investments | 4.2 M |
Conduit Pharmaceuticals Technical Analysis
Conduit Pharmaceuticals' future price can be derived by breaking down and analyzing its technical indicators over time. Conduit Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Conduit Pharmaceuticals. In general, you should focus on analyzing Conduit Stock price patterns and their correlations with different microeconomic environments and drivers.
Conduit Pharmaceuticals Predictive Forecast Models
Conduit Pharmaceuticals' time-series forecasting models is one of many Conduit Pharmaceuticals' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Conduit Pharmaceuticals' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Conduit Pharmaceuticals
Checking the ongoing alerts about Conduit Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Conduit Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Conduit Pharmaceuticals is way too risky over 90 days horizon | |
| Conduit Pharmaceuticals has some characteristics of a very speculative penny stock | |
| Conduit Pharmaceuticals appears to be risky and price may revert if volatility continues | |
| Conduit Pharmaceuticals has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (535 K) with profit before overhead, payroll, taxes, and interest of 0. | |
| Conduit Pharmaceuticals generates negative cash flow from operations | |
| Conduit Pharmaceuticals has a frail financial position based on the latest SEC disclosures | |
| Latest headline from news.google.com: Whats Going On With Conduit Pharmaceuticals Shares Today - Benzinga |
Additional Tools for Conduit Stock Analysis
When running Conduit Pharmaceuticals' price analysis, check to measure Conduit Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Conduit Pharmaceuticals is operating at the current time. Most of Conduit Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Conduit Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Conduit Pharmaceuticals' price. Additionally, you may evaluate how the addition of Conduit Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.